A Study to See if a New Type of Imaging Can Help Our Understanding of the Course of Non-small Cell Lung Cancer in Patients Undergoing Treatment With Radiation Therapy or Chemoradiotherapy
Non-small cell lung cancer (NSCLC) has a poor prognosis if not caught early enough. One of
the factors that may impact the ability to control NSCLC is low oxygen levels (hypoxia)
inside the tumour. This study will use 18F-FAZA PET scans to assess whether patients have
hypoxic tumours and to monitor the changes to the hypoxic areas of a tumour during currently
available standard treatment. It is hypothesized that 18F-FAZA PET may predict response to
treatment, local control, and/or survival in NSCLC.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society